Western blot (WB) validation using non-reducing SDS-PAGE indicated that different redox–oligoforms of PRDX2 correlated with OSA severity and OSA metabolic status [10,11]. This evidence concerns the gene PRDX2 and obstructive sleep apnea syndrome.